Clik here to view.
Promega to Celebrate the Grand Opening of Its New cGMP Facility, Feynman...
Smart Multimedia Gallery Promega to celebrate the Grand Opening of its new cGMP facility, Feynman Center, on October 11, 2013. (Photo: Business Wire) View and Share Photo Download Small MADISON,...
View ArticleClik here to view.
Otsuka Europe Development and Commercialisation Ltd., a New Company for the...
TOKYO & UXBRIDGE, United Kingdom Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the formation of Otsuka Europe Development and Commercialisation Ltd. (OEDC). Established on July 1st,...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of Decitabine for Injection
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Decitabine for Injection (50mg) a therapeutic equivalent generic version of Dacogen® (Decitabine for...
View ArticleClik here to view.
ArjoHuntleigh：大样本研究显示重度急性呼吸窘迫综合征(ARDS)患者采用俯卧位可显著降低死亡率
瑞典马尔默 (美国商业资讯) — 《新英格兰医学杂志》(2013;368:2159-2168)新近发表的一项研究得出结论认为，俯卧位（即胸部朝下）作为重度ARDS (SARDS)患者的早期干预，可显著降低死亡率，28天后降幅达50%，90天后达42% (p<0.001)。研究还发现，俯卧位患者同期的呼吸机免用天数也有显著减少。...
View ArticleClik here to view.
アルジョハントレー：大型試験にて重度急性呼吸促迫症候群(SARDS)の患者に対する腹臥位状態の適用による死亡率の有意な減少を実証
スウェーデン・マルメ (ビジネスワイヤ) —...
View ArticleClik here to view.
Anthelio® Announces New CEO
DALLAS Anthelio Healthcare Solutions (Anthelio) announced that Asif Ahmad will become its new CEO effective as of July 30, 2013. He has been Senior Vice President of Information & Technology...
View ArticleClik here to view.
Hundreds of millions of vulnerable Indian citizens lack free access to...
LONDON Modern India has the third largest national economy in the world in purchasing power adjusted terms. The country is also now the world’s largest generic medicines exporter. But 400-600...
View ArticleClik here to view.
Praxair Starts up New Air Separation Plant in Korea
DANBURY, Conn. & HWASUNG, Korea Praxair Korea, a subsidiary of Praxair, Inc. (NYSE: PX), announced the start-up of its second state-of-the-art air separation plant at the Samsung Electronics...
View ArticleClik here to view.
Phase II Clinical Data Show Statistically Significant Improvement for Lu...
BOSTON H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the presentation of the first clinical data on the investigational drug Lu AE58054 in Alzheimer’s...
View ArticleClik here to view.
Phase II Clinical Data Show Statistically Significant Improvement for Lu...
BOSTON H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the presentation of the first clinical data on the investigational drug Lu AE58054 in Alzheimer’s...
View ArticleClik here to view.
大塚製薬とルンドベック社：Lu AE58054の臨床第II相試験においてアルツハイマー型認知症治療に有効性...
東京 （ビジネスワイヤ） — 大塚製薬株式会社（本社：東京都千代田区、代表取締役社長：岩本太郎、以下「大塚製薬」）とH.ルンドベックA/S（本社：デンマーク、コペンハーゲン、CEO:ウルフ・ウインバーグ、以下「ルンドベック社」）は、開発中のアルツハイマー病治療薬Lu AE58054の臨床試験データを、ボストンで開催されたアルツハイマー病協会国際会議（AAIC...
View ArticleClik here to view.
II期临床数据显示，选择性5-HT6受体拮抗剂Lu AE58054联合多奈哌齐对阿尔茨海默病认知症状的改善效果有统计学意义...
丹麦VALBY和东京 (美国商业资讯)–丹麦灵北制药公司（H. Lundbeck A/S，以下简称“灵北”）和大冢制药株式会社（以下简称“大冢”）今天在波士顿召开的阿尔茨海默病协会2013年国际会议(AAIC 2013)上发布了研究药物Lu AE58054治疗阿尔茨海默病的首批临床数据。 该项II期临床研究显示，在多奈哌齐基础上添加Lu...
View ArticleClik here to view.
Heart Disease Treatment in Bangkok Thailand at Vejthani Hospital
BANGKOK Vejthani Hospital Bangkok offers the international standard heart disease treatment, the ways to relieve your pain at Vejthani Heart Center. We provide not only full range of medical...
View ArticleClik here to view.
Condom Availability, Accessibility and Affordability Prove Key Pieces of the...
WASHINGTON The Seventh International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lampur, Malaysia brought together 4,700 AIDS researchers, scientists,...
View ArticleClik here to view.
Taro Board Announces Senior Leadership Changes
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that Mr. Dilip Shanghvi has been appointed to Taro’s Board of Directors as its Chairman....
View ArticleClik here to view.
Leading China-Based CRO Selects Instem’s Provantis Portal for Remote Study...
CONSHOHOCKEN, Pa. Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WuXi AppTec (WuXi), a leading supplier of R&D services to the...
View ArticleClik here to view.
IMS Health Study Establishes Roadmap to Address Healthcare Access Barriers in...
DELHI, India While progress has been made in India over the past decade from both public and private sector initiatives, significant challenges persist in providing quality healthcare on an...
View ArticleClik here to view.
DaVita Expands Operations in Malaysia
DENVER DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced the acquisition of the dialysis operations of Malaysia’s...
View ArticleClik here to view.
Moberg Pharma and Menarini Extend Distribution Agreement for Kerasal Nail to...
SINGAPORE Moberg Pharma AB (OMX: MOB) today announced that Menarini Asia-Pacific, a member of the Menarini Group – a top 40 global pharmaceutical company – has been granted the exclusive rights to...
View ArticleClik here to view.
Moberg Pharma与Menarini将Kerasal Nail分销协议扩展至中国
新加坡 (美国商业资讯) — Moberg Pharma AB (OMX: MOB)今天宣布，位居全球40大制药公司之列的Menarini 集团成员Menarini Asia-Pacific已被授予Kerasal Nail™在中国的独家营销权。这两家公司目前计划申请该产品在中国市场的营销授权。 Kerasal...
View Article